Biao Xu
-
- Air Quality and Health Impacts 4
-
- Heart Failure Treatment and Management 4
- Cardiac Fibrosis and Remodeling 4
- Cardiovascular Function and Risk Factors 3
-
- Cardiac Imaging and Diagnostics 5
-
- Cardiac Ischemia and Reperfusion 4
-
- Biomarkers in Disease Mechanisms 3
-
- GDF15 and Related Biomarkers 3
- Partner nations
- ChinaSwedenUnited States
In The Last Decade
Biao Xu
43 papers receiving 863 citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Health, Toxicology and Mutagenesis 155
- Cancer Research 149
- Cardiology and Cardiovascular Medicine 153
- Nephrology 38
- Biochemistry 29
Countries citing papers authored by Biao Xu
This map shows the geographic impact of Biao Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Biao Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Biao Xu more than expected).
Fields of papers citing papers by Biao Xu
This network shows the impact of papers produced by Biao Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Biao Xu. The network helps show where Biao Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Biao Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 11 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 13 | |
| 7 | 2021 | 11 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 18 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 5 | |
| 13 | Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis | 2019 | 0 |
| 14 | 2019 | 10 | |
| 15 | 2019 | 62 | |
| 16 | 2018 | 1 | |
| 17 | 2018 | 34 | |
| 18 | 2017 | 10 | |
| 19 | 2012 | 135 | |
| 20 | [Effect of recombinant human growth hormone with total parenteral nutrition on albumin synthesis in patients with peritoneal sepsis]. | 1998 | 2 |
About Biao Xu
Biao Xu is a scholar working on Cardiology and Cardiovascular Medicine, Immunology and Biochemistry, having authored 45 papers that have together received 870 indexed citations. Recurring topics across this work include Cardiac Imaging and Diagnostics (5 papers), Air Quality and Health Impacts (4 papers), Heart Failure Treatment and Management (4 papers), Cardiac Fibrosis and Remodeling (4 papers), Cardiac Ischemia and Reperfusion (4 papers), Biomarkers in Disease Mechanisms (3 papers), Cardiovascular Function and Risk Factors (3 papers) and GDF15 and Related Biomarkers (3 papers). The work is most often cited by research in Health, Toxicology and Mutagenesis (155 citations), Cancer Research (149 citations) and Cardiology and Cardiovascular Medicine (153 citations). Biao Xu has collaborated with scholars based in China, Sweden and United States. Frequent co-authors include Jun Xie, Yihai Liu, Lina Kang, Mingyue Wu, Qiaoling Li, Jin Geng, Haixiang Sun, Jianxin Sun, Yali Hu and Guijun Yan.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.